Miracle Mile Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $784K | Buy |
2,026
+560
| +38% | +$208K | 0.01% | 500 |
|
|
2026
Q1 | $429K | Buy |
1,466
+237
| +19% | +$77.9K | 0.01% | 622 |
|
|
2025
Q4 | $431K | Sell |
1,229
-168
| -12% | -$56.8K | 0.01% | 615 |
|
|
2025
Q3 | $451K | Buy |
1,397
+307
| +28% | +$95.5K | 0.01% | 574 |
|
|
2025
Q2 | $424K | Sell |
1,090
-216
| -17% | -$86.9K | 0.01% | 512 |
|
|
2025
Q1 | $568K | Buy |
1,306
+112
| +9% | +$45K | 0.01% | 416 |
|
|
2024
Q4 | $440K | Sell |
1,194
-248
| -17% | -$104K | 0.01% | 455 |
|
|
2024
Q3 | $750K | Buy |
1,442
+56
| +4% | +$29.9K | 0.02% | 312 |
|
|
2024
Q2 | $751K | Sell |
1,386
-69
| -5% | -$36.5K | 0.02% | 299 |
|
|
2024
Q1 | $754K | Buy |
1,455
+9
| +0.6% | +$4.48K | 0.02% | 297 |
|
|
2023
Q4 | $682K | Sell |
1,446
-1,695
| -54% | -$784K | 0.02% | 304 |
|
|
2023
Q3 | $1.37M | Sell |
3,141
-30
| -0.9% | -$13.6K | 0.04% | 212 |
|
|
2023
Q2 | $1.41M | Sell |
3,171
-399
| -11% | -$184K | 0.04% | 215 |
|
|
2023
Q1 | $1.64M | Buy |
3,570
+143
| +4% | +$68.1K | 0.05% | 213 |
|
|
2022
Q4 | $1.76M | Buy |
3,427
+257
| +8% | +$130K | 0.06% | 210 |
|
|
2022
Q3 | $1.44M | Buy |
3,170
+83
| +3% | +$39.7K | 0.07% | 174 |
|
|
2022
Q2 | $1.49M | Sell |
3,087
-93
| -3% | -$46K | 0.07% | 179 |
|
|
2022
Q1 | $1.56M | Sell |
3,180
-21,204
| -87% | -$9.69M | 0.07% | 189 |
|
|
2021
Q4 | $11.3M | Buy |
24,384
+577
| +2% | +$243K | 0.44% | 54 |
|
|
2021
Q3 | $8.88M | Buy |
23,807
+697
| +3% | +$265K | 0.43% | 51 |
|
|
2021
Q2 | $8.82M | Sell |
23,110
-622
| -3% | -$238K | 0.47% | 47 |
|
|
2021
Q1 | $8.52M | Buy |
23,732
+29
| +0.1% | +$9.33K | 0.48% | 46 |
|
|
2020
Q4 | $7.61M | Buy |
23,703
+148
| +0.6% | +$45.4K | 0.47% | 49 |
|
|
2020
Q3 | $6.33M | Buy |
23,555
+1,501
| +7% | +$404K | 0.44% | 56 |
|
|
2020
Q2 | $5.8M | Sell |
22,054
-485
| -2% | -$129K | 0.48% | 48 |
|
|
2020
Q1 | $5.12M | Sell |
22,539
-3,351
| -13% | -$913K | 0.55% | 39 |
|
|
2019
Q4 | $7.82M | Buy |
25,890
+1,230
| +5% | +$338K | 0.54% | 40 |
|
|
2019
Q3 | $5.92M | Buy |
24,660
+1,219
| +5% | +$334K | 0.42% | 57 |
|
|
2019
Q2 | $6.62M | Buy |
23,441
+2,757
| +13% | +$753K | 0.49% | 50 |
|
|
2019
Q1 | $5.94M | Buy |
20,684
+18,502
| +848% | +$5.35M | 0.48% | 46 |
|
|
2018
Q4 | $573K | Hold |
2,182
| – | – | 0.07% | 83 |
|
|
2018
Q3 | $598K | Sell |
2,182
-6
| -0.3% | -$1.56K | 0.05% | 113 |
|
|
2018
Q2 | $521K | Buy |
+2,188
| New | +$507K | 0.05% | 113 |
|
|
2018
Q1 | – | Sell |
-2,174
| Closed | -$489K | – | 154 |
|
|
2017
Q4 | $489K | Buy |
+2,174
| New | +$463K | 0.08% | 58 |
|
Other funds holding ELV
Miracle Mile Advisors's ELV Position: Q2 2026 in Review
Miracle Mile Advisors increased its Elevance Health (ELV) stake by 38% in Q2 2026, buying an estimated $208K and bringing the position to 2,026 shares worth $784K. The position accounts for 0.01% of the portfolio, ranked #500.
Miracle Mile Advisors first reported a position in ELV in Q4 2017 and has held it in 34 quarters since. The position peaked at $11.3M in Q4 2021. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Miracle Mile Advisors held 2,026 shares of Elevance Health worth $784K as of Q2 2026.
- Miracle Mile Advisors bought 560 Elevance Health shares in Q2 2026, an estimated $208K.
- Elevance Health made up 0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #500 holding.
- Miracle Mile Advisors first reported a position in Elevance Health in Q4 2017 and has held it in 34 quarters since.
- Miracle Mile Advisors's Elevance Health position peaked at $11.3M in Q4 2021.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.